We are live on ! Find out more
REGN icon

Regeneron Pharmaceuticals
REGN

371 hedge funds and large institutions have $17B invested in Regeneron Pharmaceuticals in 2013 Q2 according to their latest regulatory filings, with 371 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

14% more call options, than puts

Call options by funds: $300M | Put options by funds: $263M

Holders
371
Holders Change
+371
Holders Change %
–
% of All Funds
12.11%
Holding in Top 10
9
Holding in Top 10 Change
+9
Holding in Top 10 Change %
% of All Funds
0.29%
New
371
Increased
–
Reduced
–
Closed
–
Calls
$300M
Puts
$263M
Net Calls
+$37.1M
Net Calls Change
+$37.1M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
LIM
251
Leavell Investment Management
Alabama
$967K +$1M +4,300 New
V
252
Veritable
Delaware
$961K +$995K +4,275 New
DT
253
Diversified Trust
Tennessee
$930K +$963K +4,135 New
BA
254
Bridgewater Associates
Connecticut
$922K +$955K +4,100 New
LPL Financial
255
LPL Financial
California
$868K +$899K +3,862 New
B
256
Baird
Wisconsin
$855K +$886K +3,803 New
LMGAM
257
Liberty Mutual Group Asset Management
Massachusetts
$819K +$848K +3,641 New
ACH
258
ArrowMark Colorado Holdings
Colorado
$814K +$843K +3,620 New
Schroder Investment Management Group
259
Schroder Investment Management Group
United Kingdom
$779K +$807K +3,464 New
ECAM
260
East Coast Asset Management
Massachusetts
$765K +$792K +3,401 New
AIM
261
abrdn Investment Management
United Kingdom
$742K +$768K +3,298 New
APU
262
Alpine Partners USVI
U.S. Virgin Islands
$725K +$751K +3,224 New
P
263
Pitcairn
Pennsylvania
$711K +$736K +3,162 New
PWPCM
264
Perella Weinberg Partners Capital Management
New York
$710K +$736K +3,160 New
CI
265
Constellation Investments
Ohio
$708K +$734K +3,150 New
Commonwealth Equity Services
266
Commonwealth Equity Services
Massachusetts
$704K +$729K +3,132 New
AAM
267
Azzad Asset Management
Virginia
$694K +$677K +2,908 New
ClearBridge Investments
268
ClearBridge Investments
New York
$678K +$702K +3,013 New
ACP
269
Aviance Capital Partners
Florida
$675K +$699K +3,000 New
JIC
270
Joel Isaacson & Co
New York
$675K +$699K +3,000 New
TC
271
TradeLink Capital
Illinois
$630K +$652K +2,800 New
CWM
272
Calamos Wealth Management
Illinois
$622K +$644K +2,766 New
Verition Fund Management
273
Verition Fund Management
Connecticut
$612K +$634K +2,721 New
CAS
274
CTC Alternative Strategies
Illinois
$607K +$629K +2,700 New
BBHC
275
Brown Brothers Harriman & Co
New York
$607K +$629K +2,700 New
9 10
11
12 13

REGN Hedge Fund Activity: Q2 2013 in Review

371 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Regeneron Pharmaceuticals (REGN) for Q2 2013, worth a combined $17B.

Buyers outnumbered sellers: 371 funds opened new REGN positions and 0 closed out — a net gain of 371 holders — while 0 added to existing stakes and 0 trimmed.

  • 371 institutional investors held Regeneron Pharmaceuticals (REGN) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $17B of Regeneron Pharmaceuticals stock for Q2 2013.
  • 371 funds opened new Regeneron Pharmaceuticals positions in Q2 2013 and 0 closed out, a net change of +371 holders.

Based on aggregated 13F filings for Q2 2013.